These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
364 related articles for article (PubMed ID: 10965989)
1. HMG-CoA reductase activity in human liver microsomes: comparative inhibition by statins. Dansette PM; Jaoen M; Pons C Exp Toxicol Pathol; 2000 May; 52(2):145-8. PubMed ID: 10965989 [TBL] [Abstract][Full Text] [Related]
2. Metabolic interactions between mibefradil and HMG-CoA reductase inhibitors: an in vitro investigation with human liver preparations. Prueksaritanont T; Ma B; Tang C; Meng Y; Assang C; Lu P; Reider PJ; Lin JH; Baillie TA Br J Clin Pharmacol; 1999 Mar; 47(3):291-8. PubMed ID: 10215754 [TBL] [Abstract][Full Text] [Related]
3. Comparison of the efficacies of five different statins on inhibition of human saphenous vein smooth muscle cell proliferation and invasion. Turner NA; Midgley L; O'Regan DJ; Porter KE J Cardiovasc Pharmacol; 2007 Oct; 50(4):458-61. PubMed ID: 18049315 [TBL] [Abstract][Full Text] [Related]
4. The ability of statins to inhibit bone resorption is directly related to their inhibitory effect on HMG-CoA reductase activity. Staal A; Frith JC; French MH; Swartz J; Güngör T; Harrity TW; Tamasi J; Rogers MJ; Feyen JH J Bone Miner Res; 2003 Jan; 18(1):88-96. PubMed ID: 12510809 [TBL] [Abstract][Full Text] [Related]
5. Cerivastatin triggers tumor-specific apoptosis with higher efficacy than lovastatin. Wong WW; Tan MM; Xia Z; Dimitroulakos J; Minden MD; Penn LZ Clin Cancer Res; 2001 Jul; 7(7):2067-75. PubMed ID: 11448925 [TBL] [Abstract][Full Text] [Related]
6. Analysis of five HMG-CoA reductase inhibitors-- atorvastatin, lovastatin, pravastatin, rosuvastatin and simvastatin: pharmacological, pharmacokinetic and analytical overview and development of a new method for use in pharmaceutical formulations analysis and in vitro metabolism studies. Pasha MK; Muzeeb S; Basha SJ; Shashikumar D; Mullangi R; Srinivas NR Biomed Chromatogr; 2006 Mar; 20(3):282-93. PubMed ID: 16143964 [TBL] [Abstract][Full Text] [Related]
7. Pleiotropic effects of statins in atherosclerosis and diabetes. Bellosta S; Ferri N; Arnaboldi L; Bernini F; Paoletti R; Corsini A Diabetes Care; 2000 Apr; 23 Suppl 2():B72-8. PubMed ID: 10860194 [TBL] [Abstract][Full Text] [Related]
8. Toward a role for statins in immunomodulation. Mach F Mol Interv; 2002 Dec; 2(8):478-80. PubMed ID: 14993398 [TBL] [Abstract][Full Text] [Related]
9. Hydroxymethylglutaryl-coenzyme A reductase inhibitors induce apoptosis in human cardiac myocytes in vitro. Demyanets S; Kaun C; Pfaffenberger S; Hohensinner PJ; Rega G; Pammer J; Maurer G; Huber K; Wojta J Biochem Pharmacol; 2006 Apr; 71(9):1324-30. PubMed ID: 16540096 [TBL] [Abstract][Full Text] [Related]
10. Pravastatin inhibited the cholesterol synthesis in human hepatoma cell line Hep G2 less than simvastatin and lovastatin, which is reflected in the upregulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase and squalene synthase. Cohen LH; van Vliet A; Roodenburg L; Jansen LM; Griffioen M Biochem Pharmacol; 1993 Jun; 45(11):2203-8. PubMed ID: 8517861 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of apoptosis and necrosis induced by statins using fluorescence-enhanced flow cytometry. Yasuda N; Matzno S; Iwano C; Nishikata M; Matsuyama K J Pharm Biomed Anal; 2005 Sep; 39(3-4):712-7. PubMed ID: 15927433 [TBL] [Abstract][Full Text] [Related]
12. The effect of six different statins on the proliferation, migration, and invasion of human smooth muscle cells. Corpataux JM; Naik J; Porter KE; London NJ J Surg Res; 2005 Nov; 129(1):52-6. PubMed ID: 16087194 [TBL] [Abstract][Full Text] [Related]
13. Binding thermodynamics of statins to HMG-CoA reductase. Carbonell T; Freire E Biochemistry; 2005 Sep; 44(35):11741-8. PubMed ID: 16128575 [TBL] [Abstract][Full Text] [Related]
15. Selective induction of apoptosis by HMG-CoA reductase inhibitors in hepatoma cells and dependence on p53 expression. Kah J; Wüstenberg A; Keller AD; Sirma H; Montalbano R; Ocker M; Volz T; Dandri M; Tiegs G; Sass G Oncol Rep; 2012 Sep; 28(3):1077-83. PubMed ID: 22710979 [TBL] [Abstract][Full Text] [Related]
16. Relative induction of mRNA for HMG CoA reductase and LDL receptor by five different HMG-CoA reductase inhibitors in cultured human cells. Morikawa S; Umetani M; Nakagawa S; Yamazaki H; Suganami H; Inoue K; Kitahara M; Hamakubo T; Kodama T; Saito Y J Atheroscler Thromb; 2000; 7(3):138-44. PubMed ID: 11480454 [TBL] [Abstract][Full Text] [Related]
17. Comparative study of HMG-CoA reductase inhibitors on fibrinogen. Rosenson RS; Tangney CC; Schaefer EJ Atherosclerosis; 2001 Apr; 155(2):463-6. PubMed ID: 11254918 [TBL] [Abstract][Full Text] [Related]
18. Effect of atorvastatin and fluvastatin on the metabolism of midazolam by cytochrome P450 in vitro. Mc Donnell CG; Shorten G; Van Pelt FN Anaesthesia; 2005 Aug; 60(8):747-53. PubMed ID: 16029222 [TBL] [Abstract][Full Text] [Related]
19. In vitro comparative inhibition profiles of major human drug metabolising cytochrome P450 isozymes (CYP2C9, CYP2D6 and CYP3A4) by HMG-CoA reductase inhibitors. Transon C; Leemann T; Dayer P Eur J Clin Pharmacol; 1996; 50(3):209-15. PubMed ID: 8737761 [TBL] [Abstract][Full Text] [Related]
20. Apoptotic injury in cultured human hepatocytes induced by HMG-CoA reductase inhibitors. Kubota T; Fujisaki K; Itoh Y; Yano T; Sendo T; Oishi R Biochem Pharmacol; 2004 Jun; 67(12):2175-86. PubMed ID: 15163549 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]